Medical Technology Firm
March 2016 CMS proposed rule implementing a new Part B drug payment model.   

H.R.5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models. Education about the value of innovative new medicines.

FY 2017 Labor/HHS appropriations bill as it relates to funding for newborn screening.

H.R. 6: 21st Century Cures Act.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX